Drug Database
ME

menthol (Nopika / menthol, Vinas)

✓ Approved

Vinas · 小分子 · 小分子

什么是 menthol?

menthol 是一种小分子,由Vinas研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Nopika, menthol, Vinas
公司Vinas
药物类别小分子
给药途径Topical
状态Approved

治疗适应症

menthol 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Skin and subcutaneous tissue disordersPruritus✓ Approved

相关研究文献

PubMedNPJ science of food2026-11-19

Natural deep eutectic solvent-based simultaneous extraction of aflatoxins and their precursors from edible lotus seeds.

Luo Chenghua C, Fan Xiaohong X, Zhou Yakui Y, Wu Haifeng H et al.

The early detection of aflatoxins (AFs) and their biosynthetic precursors is vital for preventing mycotoxin contamination, yet conventional extraction methods generate substantial ecological burdens due to excessive organic solvent consumption. Herein, a tailored menthol-propionic acid Natural Deep Eutectic Solvent (NADES) was developed for the simultaneous extraction of 11 AFs and their precursors from lotus seeds. This refined solvent system demonstrated satisfactory extraction efficiency when coupled with UPLC-MS/MS, and a 50% contamination incidence was observed in real samples. Notably, the NADES-based protocol showed practical advantages under the compared conditions, including over 90% organic solvent reduction and 10~20 times faster extraction than conventional methods. The extraction mechanism was further elucidated at the molecular level through integrated density functional theory (DFT) calculations and molecular dynamics simulations (MDs). Quantum chemical analysis revealed energetically favorable hydrogen bonding and hydrophobic interaction between the NADES system and aromatic rings of AFB1, while MDs further demonstrated the formation of persistent hydrogen-bond networks. This work provides a viable, eco-friendly strategy for extracting aflatoxins and their precursors, demonstrating a high potential for applications in the extraction of mycotoxins from food, feed, and herbal products.

PMID 43052339
阅读全文 →
PubMedLangmuir : the ACS journal of surfaces and colloids2026-11-17

Mechanistic Elucidation of Pharmaceutical Partitioning into Hydrophobic Deep Eutectic Solvents in Microfluidic Liquid-Liquid Extraction.

Paul Nabendu N, Banerjee Tamal T, Singh Sunil Kumar SK, Gooh Pattader Partho Sarathi PS

Understanding the molecular mechanisms governing pharmaceutical partitioning is essential for developing effective liquid-liquid extraction systems. Conventional green solvent batch extraction methods are limited by mass transfer throughput and operational discontinuity. Herein, a continuous-flow poly(dimethylsiloxane) (PDMS)-based microfluidic device was developed for liquid-liquid microextraction of ciprofloxacin and fluconazole using two DL-menthol-fatty acid-based hydrophobic deep eutectic solvents (HDESs). The influence of flow rate, residence time, and the DES/water mass ratio on extraction efficiency was evaluated. The microfluidic platform achieved higher extraction efficiencies of 89% and 75% for ciprofloxacin and fluconazole, respectively, using DL-menthol:decanoic acid (1:1) DES with a DES/water mass ratio of 1:1. Density functional theory (DFT) and molecular dynamics (MD) simulations were employed to elucidate the molecular mechanisms governing drug partitioning into DL-menthol:decanoic acid (1:1) and DL-menthol:dodecanoic acid (2:1) HDESs. Interaction energies, radial, spatial, and combined distribution functions, hydrogen bonding, noncovalent interactions (NCI), and diffusional behavior were analyzed. The findings revealed that the drug partitioning is governed by a collaborative network of hydrogen bonding (O-H···N) involving the hydroxyl/carboxyl groups of the HDES components and van der Waals dispersion interactions. The mean squared displacement (MSD) profiles further indicated reduced molecular mobility of the drug molecules within the DES-rich microenvironment, while the trajectory analysis revealed the hydrophobic nature of the DES phase. Overall, the combined experimental and molecular analysis provides mechanistic insights into drug partitioning in HDESs and illustrates how molecular interactions influence extraction performance under microfluidic liquid-liquid extraction conditions.

PMID 43043050
阅读全文 →
PubMedInternational journal of pharmaceutics2026-11-16

Transdermal delivery of cobimetinib via HPMC gel combining menthol and iontophoresis for locoregional melanoma treatment.

Jiang Changzhao C, Wang Zhixiong Z, Hu Jianling J, Wu Jialin J et al.

Orally administered cobimetinib (COBI), a selective MEK1/2 inhibitor is effective against melanoma but is associated with systemic adverse events. Herein, the HPMC-based gel combining menthol and iontophoresis was developed for locoregional transdermal delivery of COBI. Formulation was optimized via single-factor screening and an L9(33) orthogonal design. Optimized gels exhibited acceptable rheological properties and physical stability under stress conditions. In vitro permeation using excised rat abdominal skin revealed that 5% (w/w) menthol significantly enhanced COBI permeation, while iontophoresis was optimized at 3 h with 0.45% (w/w) NaCl. Based on the in vitro optimization, 0.8% (w/w) COBI loading was selected as the medium-dose candidate for subsequent in vivo efficacy evaluation (with 0.4% and 1.2% evaluated as low and high doses, respectively). In B16F10 cells, COBI combined with mild direct current showed greater inhibition of cell viability than either treatment alone. In tumor-bearing C57BL/6 mice, the optimized gelplus iontophoresis achieved achieved a tumor-weight inhibition rate of 98.2%, with histological findings suggesting increased tumor necrosis and reduced proliferation. At an equivalent dose, passive transdermal administration produced lower systemic exposure than oral dosing, whereas iontophoresis achieved comparable systemic exposure to passive delivery at half the nominal dose. In a separate mouse study, selected transdermal regimens exhibited higher tumor-to-plasma concentration ratios than oral administration at a single sampling time point. Collectively, this study demonstrates that the HPMC gel combining menthol and iontophoresis enables effective local tumor suppression.

PMID 43039121
阅读全文 →
PubMedRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)2026-11-16

A case of suspected IgE-mediated hypersensitivity to Menta piperita with identification of a possible allergenic protein through proteomic study.

Jurgens Yanina Y, Schayman Waleska W, Hernández Dolores D, Cases Bárbara B et al.

Products derived from Mentha piperita (peppermint) and Mentha spicata (spearmint) are commonly used in cosmetics and food preparation, as well as in medications for treating various gastrointestinal, cardiovascular, and respiratory disorders. A 41-year-old male patient of Italian origin was evaluated for recurrent symptoms of urticaria; he had a history of allergic rhinoconjunctivitis caused by house dust mites (Dermatophagoides pteronyssinus and Dermatophagoides farinae). During the first episode, he reported generalized urticaria 20 minutes after taking mint-flavored granulated ibuprofen (Espidifen® 600 mg), requiring emergency medical attention. In the second episode, one month later, he experienced nasal obstruction, sneezing, and rhinorrhea after chewing mint-flavored gum. In the third episode, occurring weeks later, he suffered two bouts of contact dermatitis after applying an anti-inflammatory cream containing menthol and using a mentholated shampoo. All symptoms resolved upon complete avoidance of mint-containing products. Skin prick-to-prick testing (using fresh leaves) was performed with various species from the Lamiaceae family. Only the fresh M. piperita leaf elicited a positive reaction (5 mm wheal and 4 mm erythema). Tests with basil, oregano, and thyme were negative. Molecular diagnosis (specific IgE) confirmed the reaction to M. piperita (0.4 kU/L). Given the widespread use of mint derivatives in various forms, sensitization to mint may be underdiagnosed. Mint allergy should be considered-specifically regarding potential IgE-mediated reactions-in patients with unclear diagnoses following exposure to mint-containing products.

PMID 43037218
阅读全文 →
PubMedSmall (Weinheim an der Bergstrasse, Germany)2026-11-14

Microwave Triggered NO/O2 Dual Gas Release Nano Synergistic System for Overcoming Tumor Thermotherapy Resistance and Activating Immunotherapy.

Guo Wenna W, Chen Zengzhen Z, Wu Qiong Q, Hang Lifeng L et al.

Microwave thermotherapy, as an effective physical therapy for solid tumors, often leads to treatment resistance due to limitations such as hypoxia and abnormal blood vessels, resulting in tumor residue, metastasis, and recurrence. This study constructed a microwave-responsive multifunctional nanocomposite (CCGM NCs). Using cobalt-gallium (Co-Ga) nanosheets as carriers, NO donor S-nitrosocysteine is loaded, and temperature-controlled material L-menthol is coated to form a synergistic delivery system with thermal switch characteristics. Under microwave radiation, the material simultaneously achieves three functions: acting as a microwave sensitizer to generate local thermotherapy. Catalytic generation of O2 from hydrogen peroxide decomposition within the tumor and release of NO through microwave irradiation. The synergistic effect of O2 and NO inside the tumor not only alleviates hypoxia and improves vascular function, but also generates peroxynitrite anions, which work together with thermotherapy and reactive nitrogen species to enhance tumor killing. This system can effectively induce immunogenic cell death and initiate systemic anti-tumor immune responses. Through the validation of bilateral tumor models and lung metastasis models, this strategy can efficiently ablate in situ tumors while stimulating significant distal tumor suppression and immune memory effects, effectively inhibiting tumor metastasis and recurrence.

PMID 43026676
阅读全文 →
PubMedChemistry (Weinheim an der Bergstrasse, Germany)2026-11-14

The Coordination Chemistry of Tripodal Tris-Silanolate Ligands of the "Canopy" Type.

Korber J Nepomuk JN, Nöthling Nils N, Farès Christophe C, Fürstner Alois A

Tripodal tris(silanols) of the "canopy" type are a new class of ligands able to cover a significant range of coordination chemistry. They are readily accessible, inherently modular, and structurally preorganized such that the actual complexation step is usually facile and high-yielding. At the same time, they are malleable and hence capable of accommodating metaloids and metals of the main group, the transition metal, lanthanide, and actinide series of largely different radii. They support a given metal in different oxidation states, adapt to various coordination geometries, and can coexist with a multitude of other ligands, such as neutral two-electron donors, halide, oxide, nitride, alkyl, alkylidene, alkylidyne, metallacyclobutadiene, metallatetrahedrane, metal-metal bonds, and π-bound arene. By changing the lateral substituents on the Si-linkers, the aperture of the binding site about a given central metal can be adjusted. Collectively, these virtues are enabling, most notably in catalysis. This notion has already been substantiated by the use of "canopy" complexes as state-of-the-art catalysts for alkyne metathesis and as powerful Lewis acids for the cyclization of citronellal to isopulegol as one of the key steps of the industrial menthol synthesis. Moreover, they potentially qualify as homogeneous mimics of single-site silica surface catalysts.

PMID 43031336
阅读全文 →

注册免费账户还可查看另外 4966 篇文献

免费注册查看全部文献 →

了解更多menthol